Previous close | 0.5000 |
Open | 0.5000 |
Bid | 0.4000 |
Ask | 0.6000 |
Strike | 5.00 |
Expiry date | 2024-12-20 |
Day's range | 0.5000 - 0.5000 |
Contract range | N/A |
Volume | |
Open interest | 17 |
Data from a late-stage study shows that treatment with J&J's (JNJ) experimental drug met all study endpoints in depression patients with insomnia symptoms.
Merck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a novel Wnt agonist antibody being developed for treating retinal diseases.
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...